UBS analyst Joshua Chan raised the firm’s price target on ABM (ABM) to $55 from $54 and keeps a Buy rating on the shares. Margin weakness in Q3 outweighs several positives, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABM: